Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.33 | 0.06 |
mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.27 | 0.04 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 5e-05 |
mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.0009 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.003 |